AFT is a Pharmaceutical sales and development company with operations in Australia, Malaysia, New Zealand and Singapore and out-licensing and distribution agreements around the world. AFT has four key areas of product development; [1] Patented analgesic combinations; [2] Patented cold & flu combinations; [3] Orphan drugs and [4] Patented drug delivery devices. AFT has also advanced its novel drug delivery system to pilot scale manufacture and the initiation of registration studies to tap into a significant global opportunity.
